American Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.

Press releases published on June 14, 2026

4 hours ago

Enterprise Integration Has Become the Modernization Bet Mid-Market Companies Underrate, Says APPSeCONNECT

Indeterminate EIN Presswire

5 hours ago

Gyeonggi Business and Science Accelerator Sets Off Global Scale-Up in Full Swing with the ‘1st Pan-Pan Day.’

Indeterminate EIN Presswire

6 hours ago

Venom AI Launches a Live Mentor That Turns AI Conversations Into Real Products

Indeterminate EIN Presswire

6 hours ago

Holiday Ice, Inc. Highlights Why 2,500 lb Daily Ice Output Fits Mid-Size Food Processors

Indeterminate EIN Presswire

6 hours ago

P1Mitigators Unveils InsureFENCE℠ — First AI-Powered Fencing Insurance Scope Scanner

Indeterminate EIN Presswire

12 hours ago

Dyadica Launches Breakthrough Philolaus AI Driven Brand Strategy Program to Supercharge Brand Strategy and Management

Indeterminate EIN Presswire

12 hours ago

SumGeniusAI Launches AI Copilot and Knowledge Gaps for ChatGenius DM Automation

Indeterminate EIN Presswire

13 hours ago

Z-Text Bug Bounty Goes Live: 7 ZEC On-Chain to Anyone Who Breaks It

Indeterminate EIN Presswire

13 hours ago

Online Community Service For Probation

Indeterminate EIN Presswire

2 hours ago

Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026

Indeterminate GlobeNewswire

4 hours ago

Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control

Indeterminate GlobeNewswire

8 hours ago

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting

Indeterminate GlobeNewswire

9 hours ago

Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)

Indeterminate GlobeNewswire

9 hours ago

Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026

Indeterminate GlobeNewswire

14 hours ago

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting

Indeterminate GlobeNewswire

16 hours ago

Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Indeterminate GlobeNewswire

Jun. 14, 2026

XM Announces Enhanced Trading Conditions and Opportunities for Global Traders - Featuring Partner Code 274PQ

Indeterminate GlobeNewswire